Known as COVAX, the program was supposed to be a global powerhouse, a multibillion-dollar alliance of international health bodies and nonpr...

The programme aims to distribute enough vaccines to protect at least 20% of the population in 92 low- or medium-income countries.

Gavi, the vaccine partnership playing a leading role in COVAX, announced that it would buy 110 million doses from Sinopharm and Sinovac bet...

On June 10, the company announced that it had secured 500 million doses of Pfizer/BioNTech’s Covid-19 vaccine at a not-for-profit price for...

The doses, to come on stream from October at the earliest, will broaden out the portfolio of vaccines in the Covax scheme, which has so far...

Vaccines that have not undergone a bridging trial will not be accepted, a senior government official told ET. A bridging trial is a study c...

Questions of how compensation claims would be handled in the event of any serious COVID-19 vaccine side effects, which are likely to be ver...

The Novavax vaccine has shown 90% efficacy in phase 3 clinical trials in the UK that enrolled more than 15,000 participants aged 18-84 year...

Johnson & Johnson said on Friday it had submitted for emergency use listing of its COVID-19 vaccine to the World Health Organization (WHO).

The COVAX programme has signed deals for hundreds of millions of doses to vaccinate people in poor and lower-middle income countries, but h...

The global health body has warned that such deals were driving up vaccine prices and could delay the launch of COVAX, an initiative aimed a...

Responding to a question during a press briefing on Tuesday, Union Health Secretary Rajesh Bushan said, "The Union government has not banne...

The dashboard provides a regularly updated overview of the global research and development pipeline, the projected production capacity, pub...

COVAX, the global initiative to ensure rapid and equitable access to COVID-19 vaccines for all countries, regardless of income level, annou...

Most of the rich countries have already purchased 3.8 billion doses of yet-to-be-approved Covid-19 vaccines, with an additional 5 billion d...

Bilateral deals are not a way to optimise the situation, World Health Organization’s chief scientist told, adding: “WHO is discouraging cou...

This week member states of the World Health Organisation including India have to send in their comments on their position regarding an agre...